Zimbabwe Approves Injectable Form of HIV Prevention Drug for Women
Zimbabwe has approved the use of an injectable form of pre-exposure prophylaxis (PEP) called cabotegravir to help reduce the risk of HIV in sexually active women. The injectable form is administered every two months and has been tested in clinical trials in
